
Cancer Center study if vaccines can prevent lung cancer recurrence
WLWT highlights innovative clinical trial
WLWT highlighted a University of Cincinnati Cancer Center clinical trial exploring whether personalized mRNA vaccines are effective at reducing lung cancer recurrence.
"Cancer vaccines, vaccines to prevent cancer, have been kind of the holy grail. Can we design a vaccine to prevent cancer? That's not really quite what this trial is looking at," Jennifer Leddon, MD, Cancer Center physician researcher and assistant professor in UC's College of Medicine, told WLWT. "It's really more looking at can we prevent cancer recurrence in someone who's already had cancer? That's where the personalized comes in. They make the vaccine from your cancer. They figure out what are the vulnerabilities of your cancer that they can target."
The vaccines are developed from a patient's own surgically removed tumor. In combination with immunotherapy, doctors are seeking to train the body's immune system to fight off remaining cancer cells.
"I could absolutely envision a scenario where they use the information from this study to identify common tumor antigens that are shared across many patients," Leddon said. "Not just your individual but many patients, and design a preventative vaccine based off of that."
The trial is open for patients seeking additional treatment options for lung cancer. Patients who have localized Stage II-II B (N2) lung cancer and are candidates for surgery may qualify. Patients can call 513-585-UCCC for more information.
Read about a similar pancreatic cancer vaccine trial at the Cancer Center.
Featured image at top: KRAS-driven lung cancer cells. Created by Eric Snyder, 2015. Image used courtesy of the National Institutes of Health.
Stay connected with the Cancer Center
Interested in learning more about the University of Cincinnati Cancer Center? Keep up to date by signing up for communications and newsletters based on your specific interests. Sign up for Cancer Center communications.
Related Stories
Cancer Center study if vaccines can prevent lung cancer recurrence
December 3, 2024

WLWT highlighted a University of Cincinnati Cancer Center clinical trial exploring whether personalized mRNA vaccines are effective at reducing lung cancer recurrence.
Breakthrough cancer trial offers hope for pancreatic cancer patients
March 25, 2025

Local 12 highlighted University of Cincinnati Cancer Center researcher Davendra Sohal and patient Ron Solomon who is enrolled in a pancreatic cancer trial targeting a genetic mutation called KRAS.
High-dose vitamin C shows promise in pancreatic cancer treatment
December 17, 2024

The University of Cincinnati Cancer Center's Olugbenga Olowokure was featured in a Local 12 story discussing new research from the University of Iowa that suggests that high doses of vitamin C, when combined with standard chemotherapy, may significantly extend the life expectancy of patients with advanced pancreatic cancer.